PTGX

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Protagonist Therapeutics Inc

NASDAQ | PTGX

87.03

USD

$0.00

(

0.00%

)

At Close (As of Dec 1, 2025)

$5.63B

Market Cap

136.36

P/E Ratio

0.66

EPS

$93.25

52 Week High

$33.70

52 Week Low

HEALTHCARE

Sector

PTGX Chart

Recent Chart
Price Action

PTGX Technicals

Tags:

PTGX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $434M
Total Revenue $434M
Cost Of Revenue $3M
Costof Goods And Services Sold $3M
Operating Income $253M
Selling General And Administrative $43M
Research And Development $138M
Operating Expenses $182M
Investment Income Net -
Net Interest Income $26M
Interest Income $26M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $826K
Income Before Tax $279M
Income Tax Expense $4.2M
Interest And Debt Expense -
Net Income From Continuing Operations $275M
Comprehensive Income Net Of Tax -
Ebit $253M
Ebitda $254M
Net Income $275M

Revenue & Profitability

Earnings Performance

PTGX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $745M
Total Current Assets $592M
Cash And Cash Equivalents At Carrying Value $97M
Cash And Short Term Investments $97M
Inventory -
Current Net Receivables $168M
Total Non Current Assets $153M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $140M
Short Term Investments $322M
Other Current Assets $4.2M
Other Non Current Assets -
Total Liabilities $69M
Total Current Liabilities $47M
Current Accounts Payable $1.6M
Deferred Revenue -
Current Debt -
Short Term Debt $510K
Total Non Current Liabilities $22M
Capital Lease Obligations $11M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $11M
Other Current Liabilities $24M
Other Non Current Liabilities -
Total Shareholder Equity $675M
Treasury Stock -
Retained Earnings -$341M
Common Stock $1K
Common Stock Shares Outstanding $65M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $184M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $2.9M
Capital Expenditures $1.4M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$299M
Cashflow From Financing $26M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income $275M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $434M
Total Revenue $434M
Cost Of Revenue $3M
Costof Goods And Services Sold $3M
Operating Income $253M
Selling General And Administrative $43M
Research And Development $138M
Operating Expenses $182M
Investment Income Net -
Net Interest Income $26M
Interest Income $26M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $826K
Income Before Tax $279M
Income Tax Expense $4.2M
Interest And Debt Expense -
Net Income From Continuing Operations $275M
Comprehensive Income Net Of Tax -
Ebit $253M
Ebitda $254M
Net Income $275M

PTGX News

PTGX Profile

Protagonist Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Protagonist Therapeutics, Inc. (PTGX) is a clinical-stage biopharmaceutical company specializing in the development of innovative peptide-based therapies targeting significant unmet medical needs, particularly in gastrointestinal disorders and hematological diseases. The company employs its proprietary peptide technology platform to advance a diverse pipeline of therapeutic candidates aimed at improving patient outcomes. Located in Newark, California, Protagonist is strategically focused on driving scientific innovation and addressing critical healthcare challenges, underpinned by a strong commitment to research and development. With a unique approach to peptide therapeutics, Protagonist is well-positioned to make a meaningful impact in the biopharmaceutical landscape.

LPTX
+368.57%
$2.05
DRCT
+7.89%
$0.12
PAVS
-93.54%
$0.06
KTTA
+38.67%
$1.47
QTTB
+95.43%
$4.28
KALA
+86.31%
$1.80
HBI
-1.82%
$6.47
VINE
+21.21%
$0.48
NVDA
+1.40%
$179.47
TLRY
-21.06%
$0.81
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
FTEL
+36.47%
$1.16
AXDX
-61.36%
$0.03
BITF
-6.46%
$3.25
IVP
+1.36%
$0.12
ASST
-7.14%
$1.04
ADAP
-15.14%
$0.05
CHR
+4.33%
$0.04
PLUG
+1.51%
$2.01
INTC
-1.54%
$39.93
SOND
-23.45%
$0.12
BURU
-4.62%
$0.23
RMBL
+60.50%
$3.21
BMNR
-12.19%
$29.08
LNW
-3.71%
$86.22
NIO
-5.55%
$5.19
AAL
+0.12%
$14.06
NFE
+13.11%
$1.38
ADD
-25.47%
$0.05
AHMA
+145.94%
$11.83
BMNU
-24.73%
$6.16
SRM
+53.27%
$10.30
CNEY
-15.81%
$1.22
BYND
+2.87%
$1.01
RPGL
+2.39%
$0.41
ONDS
-2.91%
$7.67
IRBT
+15.18%
$1.81
CLSK
-3.52%
$14.56
YGMZ
-0.26%
$0.11
TSLA
-0.28%
$428.92
MARA
-3.76%
$11.36
WLGS
-5.57%
$0.04
SNAP
-0.20%
$7.66
F
0.00%
$13.28
MTSR
-0.35%
$70.50
PFE
-1.61%
$25.32
SOFI
-1.05%
$29.40
ADTX
+21.01%
$3.80
INHD
-16.59%
$0.18
MSTR
-9.97%
$159.50
CAN
-6.40%
$0.94
GRAB
+2.44%
$5.45
AFMD
-34.94%
$0.18
BTG
-1.05%
$4.57
BTBT
-6.72%
$2.22
RIVN
+3.57%
$17.46
CIFR
-2.72%
$19.79
NWTN
-9.09%
$0.70
IREN
-1.32%
$47.81
GRYP
-10.38%
$1.38
HOOD
-4.68%
$122.47
AMD
+0.99%
$219.68
MODV
-25.22%
$0.43
DNN
0.00%
$2.56
NCT
-29.38%
$0.54
GOOGL
-0.76%
$317.71
SMR
+5.04%
$20.00
AG
+3.02%
$15.69
AMZN
+0.55%
$234.51
RIG
+0.80%
$4.44
EXK
-4.28%
$9.50
PLTR
-0.02%
$168.41
T
+0.77%
$26.02
PLTD
+0.05%
$7.04
AMC
+6.52%
$2.45
RUBI
-12.21%
$0.14
BBD
-1.35%
$3.65
VHAI
-25.00%
$0.00
WULF
-2.40%
$15.13
ACHR
-3.72%
$7.50
ITUB
-1.27%
$7.70
DVLT
-4.18%
$1.94
RGTI
-6.11%
$24.00
CPNG
-4.33%
$26.93
SAND
-6.04%
$12.12
BTE
+1.89%
$3.22
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
HBAN
+1.62%
$16.56
WBUY
+46.66%
$2.31
AAPL
+0.28%
$279.64
IBRX
-1.26%
$2.33
CRWV
+3.56%
$75.72
CMG
+1.43%
$34.52
HL
+2.29%
$17.20
GPUS
-7.34%
$0.28
BAC
-0.15%
$53.56
NGD
+0.17%
$8.36
CDE
-0.31%
$17.21
LPTX
+368.57%
$2.05
DRCT
+7.89%
$0.12
PAVS
-93.54%
$0.06
KTTA
+38.67%
$1.47
QTTB
+95.43%
$4.28
KALA
+86.31%
$1.80
HBI
-1.82%
$6.47
VINE
+21.21%
$0.48
NVDA
+1.40%
$179.47
TLRY
-21.06%
$0.81
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
FTEL
+36.47%
$1.16
AXDX
-61.36%
$0.03
BITF
-6.46%
$3.25
IVP
+1.36%
$0.12
ASST
-7.14%
$1.04
ADAP
-15.14%
$0.05
CHR
+4.33%
$0.04
PLUG
+1.51%
$2.01
INTC
-1.54%
$39.93
SOND
-23.45%
$0.12
BURU
-4.62%
$0.23
RMBL
+60.50%
$3.21
BMNR
-12.19%
$29.08
LNW
-3.71%
$86.22
NIO
-5.55%
$5.19
AAL
+0.12%
$14.06
NFE
+13.11%
$1.38
ADD
-25.47%
$0.05
AHMA
+145.94%
$11.83
BMNU
-24.73%
$6.16
SRM
+53.27%
$10.30
CNEY
-15.81%
$1.22
BYND
+2.87%
$1.01
RPGL
+2.39%
$0.41
ONDS
-2.91%
$7.67
IRBT
+15.18%
$1.81
CLSK
-3.52%
$14.56
YGMZ
-0.26%
$0.11
TSLA
-0.28%
$428.92
MARA
-3.76%
$11.36
WLGS
-5.57%
$0.04
SNAP
-0.20%
$7.66
F
0.00%
$13.28
MTSR
-0.35%
$70.50
PFE
-1.61%
$25.32
SOFI
-1.05%
$29.40
ADTX
+21.01%
$3.80
INHD
-16.59%
$0.18
MSTR
-9.97%
$159.50
CAN
-6.40%
$0.94
GRAB
+2.44%
$5.45
AFMD
-34.94%
$0.18
BTG
-1.05%
$4.57
BTBT
-6.72%
$2.22
RIVN
+3.57%
$17.46
CIFR
-2.72%
$19.79
NWTN
-9.09%
$0.70
IREN
-1.32%
$47.81
GRYP
-10.38%
$1.38
HOOD
-4.68%
$122.47
AMD
+0.99%
$219.68
MODV
-25.22%
$0.43
DNN
0.00%
$2.56
NCT
-29.38%
$0.54
GOOGL
-0.76%
$317.71
SMR
+5.04%
$20.00
AG
+3.02%
$15.69
AMZN
+0.55%
$234.51
RIG
+0.80%
$4.44
EXK
-4.28%
$9.50
PLTR
-0.02%
$168.41
T
+0.77%
$26.02
PLTD
+0.05%
$7.04
AMC
+6.52%
$2.45
RUBI
-12.21%
$0.14
BBD
-1.35%
$3.65
VHAI
-25.00%
$0.00
WULF
-2.40%
$15.13
ACHR
-3.72%
$7.50
ITUB
-1.27%
$7.70
DVLT
-4.18%
$1.94
RGTI
-6.11%
$24.00
CPNG
-4.33%
$26.93
SAND
-6.04%
$12.12
BTE
+1.89%
$3.22
SHOT
-74.37%
$0.39
ZAPP
-46.30%
$0.15
HBAN
+1.62%
$16.56
WBUY
+46.66%
$2.31
AAPL
+0.28%
$279.64
IBRX
-1.26%
$2.33
CRWV
+3.56%
$75.72
CMG
+1.43%
$34.52
HL
+2.29%
$17.20
GPUS
-7.34%
$0.28
BAC
-0.15%
$53.56
NGD
+0.17%
$8.36
CDE
-0.31%
$17.21
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.